CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Knight Therapeutics

For profitContributed to NMEWebsite ↗

Also known as: Knight Therapeutics (USA) Inc | KNIGHT THERAPS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

May 1, 2010

First marketed drug

Mar 19, 2014

First NDA

Mar 19, 2014

Last known activity

Jun 30, 2023

Timeline

1990s

  1. Jul 1, 1995

    Knight Therapeutics— Founded

2010s

  1. Mar 19, 2014

    miltefosine— NDA Organization

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Recent trials (2)

Details

Founded
Westmount, Quebec, CA Jul 1, 1995
First NDA
Mar 19, 2014
Last known activity
Jun 30, 2023

Designations held

  • Orphan drug
  • Fast track
  • Priority review